Osteoarthritis Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Osteoarthritis stocks.

Osteoarthritis Stocks Recent News

Date Stock Title
May 14 XOMA XOMA to Present at H.C. Wainwright 2nd Annual Bioconnect Investor Conference at NASDAQ
May 14 SNY Sanofi to make €1bn biomanufacturing investment in France
May 14 SNY Does Soaring Novavax Stock Have Enough Fuel to Climb Higher?
May 14 SNY Trending tickers: Anglo American, GameStop, Vodafone, Greggs and Novavax
May 14 SNY Fulcrum Therapeutics Inc (FULC) Q1 2024 Earnings Call Transcript Highlights: Strategic ...
May 14 SNY Exploring Three Dividend Stocks On Euronext Paris
May 13 AXSM 15 Most Depressed States in the US
May 13 SNY Barrow, Hanley, Mewhinney & Strauss Bolsters Portfolio with Strategic Additions in Q1 2024
May 13 SNY Novavax (NVAX) Q1 Earnings Miss, Stock Soars on Sanofi Deal
May 13 SNY Meme Mania is Back: Buy these 3 Stocks
May 13 SNY Healthcare Giants Pfizer, AstraZeneca, Sanofi Inject Over $2B To Boost France's Healthcare Sector
May 13 SNY Sanofi strikes $1bn deal with Fulcrum for muscular dystrophy drug
May 13 SNY Sanofi (SNY), Regeneron's Dupixent sBLA Gets FDA Priority Tag
May 13 SNY Sanofi gains license for ex-U.S. rights to Fulcrum muscular dystrophy candidate
May 13 SNY Biggest stock movers today: ARM, ZK, TME, GME, and more
May 13 SNY Fulcrum Therapeutics Q1 2024 Earnings: Misses Analyst Net Income Projections Amid Strategic ...
May 13 SNY Sanofi gambles $80M on Fulcrum’s muscular dystrophy drug
May 13 SNY France bags $16 billion investment boost from Microsoft, Pfizer and others as Macron goes on FDI charm offensive
May 13 SNY Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for First Quarter 2024
May 13 SNY Fulcrum Therapeutics Enters into a Collaboration and License Agreement with Sanofi for the Development and Commercialization of Losmapimod in Facioscapulohumeral Muscular Dystrophy
Osteoarthritis

Osteoarthritis (OA) is a type of joint disease that results from breakdown of joint cartilage and underlying bone. The most common symptoms are joint pain and stiffness. Initially, symptoms may occur only following exercise, but over time may become constant. Other symptoms may include joint swelling, decreased range of motion, and, when the back is affected, weakness or numbness of the arms and legs. The most commonly involved joints are those near the ends of the fingers, at the base of the thumb, neck, lower back, knee, and hips. Joints on one side of the body are often more affected than those on the other. Usually the symptoms come on over years. It can affect work and normal daily activities. Unlike other types of arthritis, only the joints are typically affected.Causes include previous joint injury, abnormal joint or limb development, and inherited factors. Risk is greater in those who are overweight, have one leg of a different length, and have jobs that result in high levels of joint stress. Osteoarthritis is believed to be caused by mechanical stress on the joint and low grade inflammatory processes. It develops as cartilage is lost and the underlying bone becomes affected. As pain may make it difficult to exercise, muscle loss may occur. Diagnosis is typically based on signs and symptoms, with medical imaging and other tests occasionally used to either support or rule out other problems. In contrast to rheumatoid arthritis, which is primarily an inflammatory condition, in osteoarthritis, the joints do not become hot or red.Treatment includes exercise, efforts to decrease joint stress, support groups, and pain medications. Efforts to decrease joint stress include resting and the use of a cane. Weight loss may help in those who are overweight. Pain medications may include paracetamol (acetaminophen) as well as NSAIDs such as naproxen or ibuprofen. Long-term opioid use is generally discouraged due to lack of information on benefits as well as risks of addiction and other side effects. If pain interferes with normal life despite other treatments, joint replacement surgery may help. An artificial joint typically lasts 10 to 15 years.Osteoarthritis is the most common form of arthritis, affecting about 237 million (3.3% of the population). Among those over 60 years old, about 10% of males and 18% of females are affected. It is the cause of about 2% of years lived with disability. In Australia, about 1.9 million people are affected, and in the United States, 30 to 53 million people are affected. It becomes more common in both sexes as people become older.

Browse All Tags